Total | Group | p Value | ||||
---|---|---|---|---|---|---|
A | A + 25 W | A + 35 W | A + 45 W | |||
n = 109 | n = 23 | n = 34 | n = 28 | n = 24 | ||
Age, years | 70 ± 10 | 75 ± 9 | 68 ± 10 | 69 ± 10 | 71 ± 8 | 0.056 |
Male, % | 41 | 48 | 32 | 39 | 50 | 0.508 |
Previous MI, % | 4 | 13 | 3 | 0 | 0 | 0.051 |
Previous PCI, % | 16 | 39 | 12 | 11 | 4 | 0.051 |
Cerebrovascular disease, % | 17 | 31 | 7 | 14 | 25 | 0.071 |
Peripheral artery disease, % | 8 | 22 | 3 | 7 | 4 | 0.061 |
Hypertension, % | 62 | 73 | 65 | 54 | 58 | 0.479 |
Dyslipidemia, % | 57 | 68 | 62 | 46 | 54 | 0.051 |
Diabetes mellitus, % | 41 | 46 | 38 | 46 | 33 | 0.782 |
Atrial fibrillation, % | 5 | 9 | 3 | 7 | 0 | 0.445 |
Current Smoking, % | 15 | 23 | 15 | 11 | 13 | 0.715 |
Laboratory data | ||||||
Hb, g/dL | 13.6 ± 1.7 | 12.7 ± 1.7 | 13.6 ± 1.4 | 14.1 ± 1.9 | 13.9 ± 1.8 | 0.051 |
HbA1c, % | 7.8 ± 2.6 | 6.7 ± 1.2 | 8.2 ± 2.7 | 8.4 ± 3.2 | 7.4 ± 2.5 | 0.216 |
UA, mg/dL | 5.4 ± 1.5 | 5.1 ± 0.8 | 5.2 ± 1.5 | 5.8 ± 1.8 | 5.6 ± 1.8 | 0.415 |
LDL-C, mg/dL | 122 ± 35 | 108 ± 29 | 122 ± 30 | 139 ± 35 | 113 ± 41 | 0.036 |
HDL-C, mg/dL | 54 ± 26 | 53 ± 15 | 61 ± 41 | 51 ± 10 | 48 ± 20 | 0.493 |
Creatinine, mg/dL | 0.92 ± 0.64 | 1.23 ± 1.15 | 0.77 ± 0.21 | 0.81 ± 0.37 | 0.97 ± 0.45 | 0.054 |
BNP, pg/mL | 49 (22, 78) | 58 (22, 208) | 48 (23, 68) | 59 (15, 65) | 40 (11, 63) | 0.067 |
Medications | ||||||
ADA, % | 22 | 14 | 27 | 29 | 17 | 0.167 |
ATA, % | 22 | 36 | 27 | 11 | 17 | 0.192 |
β blocker, % | 14 | 14 | 18 | 18 | 4 | 0.440 |
CCB, % | 46 | 55 | 47 | 46 | 38 | 0.634 |
Diuretics, % | 8 | 14 | 6 | 11 | 4 | 0.374 |
Nitrates, % | 7 | 14 | 9 | 7 | 0 | 0.636 |
RAS-I, % | 37 | 36 | 27 | 36 | 54 | 0.075 |
Statin, % | 41 | 57 | 44 | 21 | 42 | 0.462 |